Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Cardiologists have implanted Chicago-based Abbott Laboratories' new dissolving heart stent into the first patients, according to The Wall Street Journal.
Sage Therapeutics experimental drug to treat postpartum depression showed positive results in a recent mid-stage study, according to Reuters.
The Food and Drug Administration approved Shire's new treatment for the signs and symptoms of dry eye disease.
The Food and Drug Administration approved the Exablate Neuro system as the first focused ultrasound device intended to treat essential tremor in patients who do not respond to conventional medication.
AbbVie's popular arthritis drug Humira is a powerhouse, producing $14 billion in annual sales to make up 60 percent of the drugmaker's revenue. However, generic versions of the drug are around the corner, threatening Humira's domination in the market, according…
The Food and Drug Administration recently approved Amgen's Repatha Pushtronex system.
The Food and Drug Administration approved Lannett's paroxetine extended release tablets.
Getinge Group, based in Wayne, N.J., earned approval from the Food and Drug Administration for expanded indications of its Sterizone VP4 Sterilizer.
Kevin Tracey, MD, president of the Feinstein Institution for Medical Research in Manhasset, N.Y., believes bioelectronic medicine could have widespread use within the next five to 10 years, according to The Wall Street Journal.
While the amount of new drug shortages has mostly decreased since 2011, there is still a large amount of ongoing drug shortages, according to a new report by the Government Accountability Office.